As critical players in gene regulation, RNA binding proteins (RBPs) are taking center stage in our understanding of cellular function and disease. In our era of bench-top sequencers and unprecedented computational power, biological questions can be addressed in a systematic, genome-wide manner. Development of high-throughput sequencing (Seq) methodologies provides unparalleled potential to discover new mechanisms of disease-associated perturbations of RNA homeostasis. Complementary to candidate single-gene studies, these innovative technologies may elicit the discovery of unexpected mechanisms, and enable us to determine the widespread influence of the multifunctional RBPs on their targets. Given that the disruption of RNA processing is increasingly implicated in neurological diseases, these approaches will continue to provide insights into the roles of RBPs in disease pathogenesis.
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RBPs and RNA processing If DNA is the blueprint for a cell, then transcribed RNA represents bits of information retrieved from DNA to direct cellular function and promote cell survival. Before guiding cell function, these nascent RNAs must first undergo extensive processing and precise localization, both of which are dynamic processes that require complex interplay among proteins interacting with RNA, known as RBPs (see Glossary). As with any multistep, multicomponent procedure, exact homeostatic control of RNA processing is essential for the sustained health and proper function of the eukaryotic cell. RBPs bind to specific sequences or secondary structures within the RNA molecule to modulate co-and post-transcriptional processing steps (Figure 1 ).
Opportunities for misregulation of RNA processing abound, often caused by mutations within RBP binding sites or in the RBPs themselves, altering RBP-RNA interactions. Such dysfunction has been identified as the culprit
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Glossary
Crosslink: formation of a covalent bond between two entities. In the context of this review, crosslinking refers to the formation of covalent bonds between protein and nucleic acid that are within close physical proximity (within a few angstroms). They can be chemical and reversible (formaldehyde), or photochemical and irreversible (UV light). Library: the pooled sample of fragmented nucleic acids having the necessary adapters for high-throughput sequencing. Polyadenylation: the process of adding multiple adenosine residues to the 3 0 end of transcripts. The poly(A) tail is necessary for nuclear export as well as protecting the 3 0 end of the transcript from exonuclease degradation. Poly(A) sites can be located within introns, exons or the 3 0 UTR of a transcript; however, poly(A) sites in the 3 0 UTR are more commonly utilized in vivo. Alternative polyadenylation is a common phenomenon in which one of many potential poly(A) sites available is favored. Use of a poly(A) site depends on the core 3 0 -processing machinery, the strength of cis-elements, transcription dynamics, and other auxiliary factors [119] . Randomer: for a defined length of nucleic acid, the set of oligomers with all possible sequences. Read-mapping: the process of aligning short sequencing reads to a reference genome or sequence. RNA-binding protein (RBP): a protein that interacts with RNA to affect downstream function or processing. RNA element: sequence of RNA that is often conserved and has a particular function, for example as a binding site for an RBP. RNA splicing: the process of excising non protein-coding regions of pre-mRNA, called introns, and the joining of exons. The preferential inclusion or exclusion of an exon is termed 'alternative splicing' and contributes significantly to the diversity of the proteome. RNA splint ligation: the ligation of two RNA molecules brought together via binding of a third bridging oligonucleotide complementary to the two RNA molecules. RNA turnover: the process of RNA degradation. There are several known mechanisms, all of which involve the recruitment and function of several RBPs [120] . Most RNAs are degraded in a deadenylation-independent manner, in which the poly(A) tail is shortened, followed by removal of the 5 0 cap, enabling exonuclease degradation of the RNA. Transcripts can also be targeted for degradation without deadenylation or decapping via miRNA-mediated recruitment of the RNA-induced silencing complex (RISC) complex. Another deadenylation-independent mechanism of RNA turnover is nonsense-mediated decay (NMD), where the interaction of RBPs Upf1, Upf3, and Nmd2 with mRNAs that contain premature stop codons results in decapping and degradation by exonucleases [121] . RNAs lacking a stop codon are also rapidly deadenylated and subjected to decapping and exonuclease degradation in a pathway known as 'nonstop decay' [122, 123] . Sequencing adapter: defined nucleic acid sequences ligated to the end of the nucleic acid fragments of interest before sequencing; enables hybridization to a sequencing flow cell as well as recognition by the sequencing primer. Untranslated region (UTR): the regions at the 5 0 and 3 0 ends of transcripts that do not encode protein, but often harbor cis-regulatory elements that are bound by protein.
